Liver biopsies in chronic viral hepatitis: Beyond grading and staging

Archives of Pathology and Laboratory Medicine

Volumn 135, Issue 10, 2011, Pages 1320-1328

  Hudacko, Rachel ^a   Theise, Neil ^b  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOPSY; CHRONIC DISEASE; DISEASE COURSE; FATTY LIVER; HEMOSIDEROSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER; LIVER CELL CARCINOMA; LIVER TUMOR; PATHOLOGY; RISK FACTOR; VIRUS HEPATITIS;

BIOPSY; CARCINOMA, HEPATOCELLULAR; CHRONIC DISEASE; DISEASE PROGRESSION; FATTY LIVER; HEMOSIDEROSIS; HEPATITIS, VIRAL, HUMAN; HIV INFECTIONS; HUMANS; LIVER; LIVER NEOPLASMS; RISK FACTORS;

EID: 80055073919     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/arpa.2011-0021-RA     Document Type: Article

References (83)

1. De Groote J, Desmet VJ, Gedigk P, et al. A classification of chronic hepatitis. Lancet. 1968;2(7568):626-628.
2. Scheuer PJ. The "Gnomes": an adventure in hepatopathology. Ann Diagn Pathol. 1999;3(2):134-139.
3. Popper H, Schaffner F. The vocabulary of chronic hepatitis. N Engl J Med. 1971;284(20):1154-1156.
4. Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1981 ;1(5):431-435. (Pubitemid 12218164)
5. Scheuer PJ. Classification of viral hepatitis: a need for reassessment. J Hepatol. 1991;13(3):372-374.
6. Batts KP, Ludwig J. Chronic hepatitis: an update on terminology and reporting. Am J Surg Pathol. 1995;19(12):1409-1417.
7. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol. 1995;22(6):696-699.
8. Bedossa P, Bioulac-Sage P, Callard P, et al; French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsies in patients with chronic hepatitis C. Hepatology. 1994;20(1):15-20. (Pubitemid 24196485)
9. Bedossa P, Poynard T; for the French METAVIR Cooperative Study Group. An algorithm for grading activity in chronic hepatitis C. Hepatology. 1996,24(2): 289-293. (Pubitemid 26260021)
10. Brunt EM. Grading and staging the histopathological lesions of chronic hepatitis: the Knodell histology activity index and beyond. Hepatology. 2000; 31(1):241-246. (Pubitemid 30033714)
11. Scheuer PJ, Standish RA, Dhillon AP. Scoring of chronic hepatitis. Clin Liver Dis. 2002;6(2):335-347. (Pubitemid 34755895)
12. Theise ND. Liver biopsy assessment in chronic viral hepatitis: a personal, practical approach. Mod Pathol. 2007;20(suppl 1):S3-S14. (Pubitemid 46733659)
13. Levy CM, Popper H, Sherlock S. Diseases of the Liver and Biliary Tract: Standardization of Nomenclature, Diagnostic Criteria, and Prognosis. Washington, DC: National Institutes of Health; 1976. NIH publication 76-725; Fogarty International Center Proceeding 22.
14. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading, and staging. Hepatology. 1994; 19(6): 1513-1520. (Pubitemid 24166476)
15. Poynard T, Bedossa P, Opolon P; for the OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet. 1997;349(9055):825-832. (Pubitemid 27129209)
16. Deuffic S, Buffat L, Poynard T, Valleron AJ. Modeling the hepatitis C virus epidemic in France. Hepatology. 1999;29(5):1596-1601. (Pubitemid 29211066)
17. Roffi L, Redaelli A, Colloredo G, et al. Outcome of liver disease in a large cohort of histologically proven chronic hepatitis C: influence of HCV genotype. Eur I Gastroenterol Hepatol. 2001;13(5):501-506. (Pubitemid 32466251)
18. Davis GL, Lau JYN. Factors predictive of a beneficial response to therapy of hepatitis C. Hepatology. 1997;26(3)(suppl 1):122S-127S. (Pubitemid 27388084)
19. Hoofnagle JH, Doo E, Liang TJ, Fleischer R, Lok ASL. Management of hepatitis B: summary of a clinical research workshop. Hepatology. 2007;45(4): 1056-1075. (Pubitemid 46646501)
20. McMahon BJ. The natural history of chronic hepatitis B virus infection. Hepatology. 2009,49(5 suppl):S45-S55.
21. Liaw YF, Yang SS, Chen TJ, Chu CM. Acute exacerbation in hepatitis B e antigen positive chronic type B hepatitis: a clinicopathological study. J Hepatol. 1985;1(3):227-233.
22. Lok ASF, Lindsay I, Scheuer PJ, Thomas HC. Clinical and histological features of delta infection in chronic hepatitis B virus carriers. J Clin Pathol. 1985; 38(5):530-533. (Pubitemid 15052722)
23. Liaw YF, Tai DI, Chu CM, Chen TJ. The development of cirrhosis in patients with chronic type B hepatitis: a prospective study. Hepatology. 1988; 8(3):493-496.
24. Alvarez F, Berg PA, Bianchi FB, et al. International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31 (5):929-938. (Pubitemid 29514229)
25. Roberts SK, Therneau TM, Czaja AJ. Prognosis of histological cirrhosis in type 1 autoimmune hepatitis. Gastroenterol. 1996;110(3):848-857. (Pubitemid 26071852)
26. Czaja AJ, Carpenter HA. Decreased fibrosis during corticosteroid therapy of autoimmune hepatitis. J Hepatol. 2004;40(4):646-652. (Pubitemid 38367787)
27. Czaja AJ, Carpenter HA. Progressive fibrosis during corticosteroid therapy of autoimmune hepatitis. Hepatology. 2004;39(6):1631-1638. (Pubitemid 38702664)
28. Lee RG. General principles. In: Lee RG, ed. Diagnostic Liver Pathology. St Louis, MO: Mosby-Year Book, 1994:1-21.
29. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med. 2001;344(7): 495-501.
30. Colloredo G, Guido M, Sonzogni A, Leandro G. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol. 2003;39(2):239-244. (Pubitemid 36920560)
31. Guido M, Rugge M. Liver biopsy sampling in chronic viral hepatitis. Semin Liver Dis. 2004;24(1):89-97. (Pubitemid 38496051)
32. Schiano TD, Azeem S, Bodian CA, et al. Importance of specimen size in accurate needle liver biopsy evaluation of patients with chronic hepatitis C. Clin Gastroenterol Hepatol. 2005;3(9):930-935. (Pubitemid 41219298)
33. Regev A, Berho M, Jeffers LJ, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol. 2002;97(10):2614-2618.
34. Skripenova S, Trainer TD, Krawitt EL, Blaszyk H. Variability of grade and stage in simultaneous paired liver biopsies in patients with hepatitis C. J Clin Pathol. 2007;60(3):321-324. (Pubitemid 46447752)
35. Fanning L, Loane J, Kenny-Walsh E, et al. Tissue viral load variability in chronic hepatitis C. Am J Gastroenterol. 2001;96(12):3384-3389. (Pubitemid 34016664)
36. Persico M, Palmentieri B, Vecchione R, Torello R, de Sio I. Diagnosis of chronic liver disease: reproducibility and validation of liver biopsy. Am J Gastroenterol. 2002;97(2):491-492. (Pubitemid 34160789)
37. Bach N, Thung SN, Schaffner F. The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis. Hepatology. 1992;15(4):572-577.
38. Hourigan LF, Macdonald GA, Purdie D, et al. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. Hepatology. 1999; 29(4):1215-1219. (Pubitemid 29168757)
39. Rubbia-Brandt L, Quadri R, Abid K, et al. Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3. J Hepatol. 2000;33(1):106-115. (Pubitemid 30418941)
40. Hwang SJ, Luo JC, Chu CW, et al. Hepatic steatosis in chronic hepatitis C virus infection: prevalence and clinical correlation. J Gastroenterol Hepatol. 2001;16(2):190-195.
41. Adinolfi LE, Gambardella M, Andreano A, Tripodi MF, Utili R, Ruggiero G. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology. 2001;33(6):1358-1364. (Pubitemid 32496971)
42. Fartoux L, Poujol-Robert A, Guechot J, Wendum D, Poupon R, Serfaty L. Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C. Gut. 2005;54(7): 1003-1008. (Pubitemid 40873917)
43. Vanni E, Abate ML, Gentilcore E, et al. Sites and mechanisms of insulin resistance in nonobese, nondiabetic patients with chronic hepatitis C. Hepatology. 2009;50(3):697-706.
44. Lefkowitch JH, Schiff ER, Davis GL, et al; The Hepatitis Interventional Therapy Group. Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. Gastroenterology. 1993;104(2):595-603. (Pubitemid 23033436)
45. Hezode C, Roudot-Thoraval F, Zafrani ES, Dhumeaux D, Pawlotsky JM. Different mechanisms of steatosis in hepatitis C virus genotypes 1 and 3 infections. ; Viral Hepat. 2004;11(5):455-458. (Pubitemid 39336228)
46. Yoon EJ, Hu K. Hepatitis C virus (HCV) infection and hepatic steatosis. Int J Med Sci. 2006;3(2):53-55.
47. Kumar D, Farrell GC, Fung C, George J. Hepatitis C virus genotype 3 is cytopathic to hepatocytes: reversal of hepatic steatosis after sustained therapeutic response. Hepatology. 2002;36(5):1266-1272. (Pubitemid 35253445)
48. Poynard T, Ratziu V, McHutchison J, et al. Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C. Hepatology. 2003,38(1 ):75-85. (Pubitemid 36775798)
49. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology. 2006:43(2):S99-112.
50. Brunt EM. Nonalcoholic steatohepatitis. Semin Liver Dis. 2004;24(1):3-20. (Pubitemid 38496045)
51. Allory Y, Charlotte F, Benhamou Y, Opolon P, Le Charpentier Y, Poynard T. Impact of human immunodeficiency virus infection on the histological features of chronic hepatitis C: a case-control study. Human Pathol. 2000;31(1):69-74. (Pubitemid 30054390)
52. Soto B, Sanchez-Quijano A, Rodrigo L, et al. Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. J Hepatol. 1997;26(1):1-5. (Pubitemid 27072597)
53. Benhamou Y, Bochet M, Di Martino V, et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. Hepatology. 1999;30(4): 1054-1058. (Pubitemid 29458296)
54. Colin JF, Cazals-Hatem D, Loriot MA, et al. Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men. Hepatology. 1999;29(4):1306-1310. (Pubitemid 29168769)
55. Soriano V, Puoti M, Peters M, et al. Care of HIV patients with chronic hepatitis B: updated recommendations from the HIV-Hepatitis B virus international panel. AIDS. 2008;22(12):1399-1410.
56. Xiao SY, Lu L, Wang HL. Fibrosing cholestatic hepatitis: clinicopathologic spectrum, diagnosis, and pathogenesis. Int J Clin Exp Pathol. 2008;1(5):396-402.
57. Marks KM, Petrovic LM, Talal AH, Murray MP, Gulick RM, Glesby MJ. Histological findings and clinical characteristics associated with hepatic steatosis in patients coinfected with HIV and hepatitis C virus. J Infect Dis. 2005;192(11): 1943-1949. (Pubitemid 41681892)
58. Sulkowski MS, Mehta SH, Torbenson M, et al. Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus. AIDS. 2005;19(6):585-592. (Pubitemid 40543981)
59. Gaslightwala I, Bini EJ. Impact of human immunodeficiency virus infection on the prevalence and severity of steatosis in patients with chronic hepatitis C virus infection. J Hepatol. 2006;44(6):1026-1032.
60. Carr A, MillerJ, Law M, Cooper DA. A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome. AIDS. 2000;14(3):F25-F32. (Pubitemid 30132938)
61. Sagnelli E, Pasquale C, Coppola N, et al. Influence of chronic coinfection with hepatitis B and C virus on liver histology. Infection. 2004;32(3):144-148. (Pubitemid 38757018)
62. Donato F, Boffetta P, Puoti M. A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma. Int J Cancer. 1998;75(3):347-354. (Pubitemid 28100034)
63. Koike K, Yotsuyanagi H, Moriya K, et al. Dominant replication of either virus in dual infection with hepatitis viruses B and C. J Med Virol. 1995;45(2):236-239.
64. Raimondo G, Brunetto MR, Pontisso P, et al. Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus-hepatitis C virus-coinfected patients. Hepatology. 2006,43(1 ):100-107. (Pubitemid 43733596)
65. Batts KP. Iron overload syndromes and the liver. Mod Pathol. 2007;20(S1): S31-39. (Pubitemid 46733661)
66. Ludwig J, Hashimoto E, Porayko MK, Mover TP, Baldus WP. Hemosiderosis in cirrhosis: a study of 447 native livers. Gastroenterology. 1997;112(3): 882-688.
67. Girelli D, Pasino M, Goodnough JB, et al. Reduced serum hepcidin levels in patients with chronic hepatitis C. J Hepatol. 2009;51(5):845-852.
68. Tsochatzis E, Papatheodoridis GV, Koliaraki V, et al. Serum hepcidin levels are related to the severity of liver histological lesions in chronic hepatitis C. J Viral Hepatitis. 2010;17(11):80-86.
69. Fiel MI, Schiano TD, Guido M, et al. Increased hepatic iron deposition resulting from treatment of chronic hepatitis C with ribavirin. Am J Clin Pathol. 2000;113(1):35-39. (Pubitemid 30217338)
70. Beinker NK, Voigt MD, Adrendse M, Smit J, Stander IA, Kirsch RE. Threshold effect of liver iron content on hepatic inflammation and fibrosis in hepatitis B and C. J Hepatol. 1996;25(5):633-638. (Pubitemid 26373878)
71. Metwally MA, Zein CO, Zein NN. Clinical significance of hepatic iron deposition and serum iron values in patients with chronic hepatitis C infection. Am J Gastroenterol. 2004;99(2):286-291. (Pubitemid 38279871)
72. Hayashi H, Takikawa T, Nishimura N, Yano M, Isomura T, Sakamoto N. Improvement of serum aminotransferase levels after phlebotomy in patients with chronic active hepatitis C and excess hepatic iron. Am J Gastroenterol. 1994; 89(7):986-988. (Pubitemid 24201831)
73. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T. Penetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet. 2002; 359(9302):211-218. (Pubitemid 34113819)
74. Marchio A, Terris B, Meddeb M, et al. Chromosomal abnormalities in liver cell dysplasia detected by comparative genomic hybridisation. Mol Pathol. 2001; 54(4):270-274. (Pubitemid 32730405)
75. Lee RG, Tsamandas AC, Demetris AJ. Large cell change (liver cell dysplasia) and hepatocellular carcinoma in cirrhosis: matched case-control study, pathological analysis, and pathogenetic hypothesis. Hepatology. 1997; 26(6):1415-1422. (Pubitemid 27520005)
76. Borzio M, Bruno S, Roncalli M, et al. Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: a prospective study. Gastroenterology. 1995;108(3):812-817.
77. Ganne-Carrie N, Chastang C, Chapel F, et al. Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis. Hepatology. 1996;23(5):1112-1118. (Pubitemid 26137055)
78. Kim H, Oh BK, Roncalli M, et al. Large liver cell change in hepatitis B virus-related liver cirrhosis. Hepatology. 2009;50(3):752-762.
79. Ferrell L. Short course in liver pathology: cirrhosis, hepatitis, and primary liver tumors. Update and diagnostic problems. Mod Pathol. 2000;13(6):679-704. (Pubitemid 30436806)
80. Wanless IR; International Working Party. Terminology of nodular hepatocellular lesions. Hepatology. 1995;22(3):983-993.
81. Deugnier YM, Charalambous P, Le Quilleuc D, et al. Preneoplastic significance of hepatic iron-free foci in genetic hemochromatosis: a study of 185 patients. Hepatology. 1993;18(6):1363-1369. (Pubitemid 23348423)
82. Terada T, Nakanuma Y. Iron-negative foci in siderotic macroregenerative nodules in human cirrhotic liver: a marker of incipient neoplastic lesions. Arch Pathol lab Med. 1989;113(8):916-920. (Pubitemid 19206397)
83. Terada T, Kadoya M, Nakanuma Y, Matsui O. Iron-accumulating adenomatous hyperplastic nodule with malignant foci in the cirrhotic liver. Histopathologic, quantitative iron, and magnetic resonance imaging in vitro studies. Cancer. 1990;65(9):1994-2000. (Pubitemid 20147639)